BD 515052 - Phaseal Injector N35-O Closed-System Transfer Injector for Hazardous Drug Handling, 200/CS

BD 515052 - Phaseal Injector N35-O Closed-System Transfer Injector for Hazardous Drug Handling, 200/CS

The BD 515052 Phaseal Injector N35-O is a sterile, single-use component of the BD Phaseal Closed-System Transfer Device (CSTD). Engineered for safe and leak-free handling of hazardous drugs, this injector connects securely to medication vials and enables closed transfer of chemotherapy and other cytotoxic agents. Its advanced design minimizes vapor release, drug exposure, and contamination risk during preparation, transfer, and administration.

Key Benefits

The Phaseal Injector N35-O provides airtight, leak-proof drug transfer to protect healthcare workers and maintain drug sterility. Its integrated expansion chamber and pressure-equalization technology reduce aerosolization, helping prevent hazardous drug escape into the environment. The secure locking mechanism ensures a stable connection between components, and the smooth, intuitive operation supports efficient workflow in pharmacy compounding and infusion areas.

Compatibility and Applications

This injector is compatible with:

• BD Phaseal systems and connectors
• Standard Luer-Lok drug transfer systems
• Most chemotherapy and hazardous drug vials

Common applications include:

• Preparation of chemotherapy drugs
• Safe transfer of hazardous medications
• Closed-system compounding in cleanrooms
• IV preparation workflows in hospitals and oncology centers

Usage Guidelines

Attach the injector to the drug vial using aseptic technique and ensure a secure connection. Engage the Phaseal components to create a fully closed transfer pathway. Withdraw or transfer medication per facility protocol, ensuring no forceful pressure that might compromise system integrity. Dispose of all used components in accordance with hazardous drug and sharps disposal regulations.

Certifications, Safety Standards, and Regulatory Approvals

The Phaseal Injector N35-O meets USPguidelines for hazardous drug handling and is cleared by the FDA as an ONB (OncologyNursing/Pharmacy) closed-system transfer device. Manufactured under ISO 9001 and ISO 13485 certified processes, it ensures sterility, durability, and consistent leak-proof performance.

Comparison with Competitor Products

Compared with other CSTD injectors, BD Phaseal components are widely recognized for superior leak resistance, better vapor containment, and highly reliable pressure equalization. Many competing products rely on mechanical valves that may release aerosolized drug particles, while Phaseal uses a double-membrane design proven to reduce contamination and occupational exposure.

Typical User Profile and Application Scenarios

Used primarily by:

• Oncology pharmacists and pharmacy technicians
• Nurses administering chemotherapy
• Hospital and infusion center compounding teams
• Facilities handling cytotoxic and hazardous drugs

Best Practices for Use and Maintenance

Always follow USPprotocols and institutional hazardous drug guidelines. Ensure all Phaseal system components are compatible before use. Maintain aseptic technique throughout drug preparation. Do not reuse or attempt to re-sterilize the injector. Store unused components in controlled, clean conditions.

Regulatory and Safety Information

Single-use only. Sterile unless packaging is opened or damaged. Handle all hazardous drugs using appropriate PPE and engineering controls. Dispose of used injectors per hazardous waste and sharps disposal regulations.

How to Order

To order the BD 515052 Phaseal Injector N35-O, add the item to your cart and complete checkout through CIA Medicals secure online ordering system. For bulk orders, oncology department supply planning, or product assistance, contact CIA Medical customer service at (312) 275-5850 or submit an inquiry using the form on this page.